Penile cancer: current therapy and future directions von Sonpavde, G., Pagliaro, L.C., Buonerba, C., Dorff, T.B., Lee, R.J., Di Lorenzo, G.

Volltext

Management and challenges of corticosteroid therapy in men with metastatic castrate-resistant prostate cancer von Dorff, T.B., Crawford, E.D.

Volltext

Patient experience in the treatment of metastatic castration-resistant prostate cancer: state of the science von Nussbaum, N, George, D J, Abernethy, A P, Dolan, C M, Oestreicher, N, Flanders, S, Dorff, T B

Volltext

Prostatectomy at high-volume centers improves outcomes and lowers the costs of care for prostate cancer von Barzi, A, Klein, E A, Dorff, T B, Quinn, D I, Sadeghi, S

Volltext

A review of clinical effects associated with metabolic syndrome and exercise in prostate cancer patients von Kiwata, J L, Dorff, T B, Schroeder, E T, Gross, M E, Dieli-Conwright, C M

Volltext

Speeding dating for docetaxel and recent debutantes in castration-resistant prostate cancer: ‘plus or minus’ may be a minus von Dorff, T.B., Quinn, D.I.

Volltext

A Phase II trial of a combination herbal supplement for men with biochemically recurrent prostate cancer von Dorff, T B, Groshen, S, Tsao-Wei, D D, Xiong, S, Gross, M E, Vogelzang, N, Quinn, D I, Pinski, J K

Volltext

Testis cancer: on gilding the lily von Raghavan, D.

Volltext

Abstract P3-12-14: Incidence of radiation induced sarcoma attributable to radiotherapy in adults: A population-based study of the SEER cancer registry across 17 primary tumor sites von Snow, AE, Struycken, LC, Koc, M, Greco, JP, Zhu, Y, In, GK, Dorff, TB, Lang, JE

Volltext

Speeding dating for docetaxel and recent debutantes in castration-resistant prostate cancer: 'plus or minus' may be a minus von Dorff, T B, Quinn, D I

Volltext

LH-receptor polymorphisms and response to androgen deprivation therapy in prostate cancer von Liu, S. V., Dorff, T. B., Wang, Q., Xiong, S., Thara, E., Keng, M., Ingles, S. A., Pinski, J. K.

Volltext

Retrospective claims database cost analysis of second-line sorafenib (SR) or sunitinib (SR) therapy in treatment of patients (pts) with renal cell carcinoma (RCC) von Moyneur, E., Dorff, T. B., Barghout, V., Meyers, S., Hu, J., Quinn, D. I.

Volltext

Sequential active chemotherapy schema in castration-resistant prostate cancer von Tang, R., Groshen, S. G., Piatek, C. I., Desai, B. B., Pinski, J. K., Acosta, F., Raghavan, D., Dorff, T. B., Quinn, D. I.

Volltext

RECIST 1.0 versus 1.1: Implications for trial interpretation and design in advanced prostate cancer von Piatek, C. I., Desai, B. B., Wei-Tsao, D., Tang, R., Acosta, F., Pinski, J. K., Dorff, T. B., Goldkorn, A., Jadvar, H., Quinn, D. I.

Volltext

Risk stratification and stage migration effect of novel imaging and biomarker technology in men with biochemical failure after local therapy for prostate cancer von Desai, B. B., Quinn, D. I., Piatek, C. I., Tang, R., Hu, J., Goldkorn, A., Gross, M. E., Hawes, D., Jadvar, H., Dorff, T. B.

Volltext

Evaluation of patients, safety, and financial implications of sipuleucel-T (SipT) for treatment of metastatic castrate-resistant prostate cancer (mCRPC): Early real-world experienc... von Pak, S., Reed, M., Luther, M., Averia, M., Desai, S., Pinski, J. K., Dorff, T. B., Quinn, D. I., Chan, B.

Volltext

Molecular markers and outcomes in penile squamous cancer (PSC) von Dorff, T. B., Schuckman, A., Schwartz, R., Danenberg, K., Ma, Y., Cai, J., Rashad, S., Skinner, E. C., Quinn, D. I., Pinski, J. K.

Volltext

Impact of dose density of adjuvant chemotherapy for locally advanced urothelial cancer von Dorff, T. B., Cai, J., Miranda, G., Skinner, E. C., Schuckman, A., Groshen, S. G., Quinn, D. I.

Volltext

EGFR, TS, and ERCC1 expression in penile squamous cancer (PSC) von Dorff, T. B., Schwartz, R., Ma, Y., Cai, J., Bulbul, A., Skinner, E. C., Quinn, D. I., Danenberg, K., Schuckman, A.

Volltext

Prostate cancer metastases to bone: Pathophysiology, pain management, and the promise of targeted therapy von Pinski, Jacek, Dorff, Tanya B.

Volltext